Which of the following medications increases the risk of medication-related osteonecrosis of the jaw? A Comprehensive Guide
•
2 min read
According to the American Association of Oral and Maxillofacial Surgeons (AAOMS), the risk of medication-related osteonecrosis of the jaw (MRONJ) is significantly higher for patients on high-dose intravenous bisphosphonates or denosumab, with incidence ranging from 1% to 10%. This article will explore which of the following medications increases the risk of medication-related osteonecrosis of the jaw, outlining the associated risk factors and management strategies.
